← Leaderboards
Alan C Geller
Boston University Medical Campus
$7,250,920
Attributed
$9,301,671
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $919.2K · FY2005–24$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$9,301,671 · 4
By mechanism
R01$7,475,513 · 2
R25$1,602,850 · 1
P50$223,308 · 1
Top collaborators
- Saro Armenian5 shared
Most similar at Boston University Medical Campus
Same institution · by research overlap
- Stephen A Morash$6,952,327
- Anita L Destefano$8,148,271
- Marianne N Prout$828,713
- Elena Losina$29,697,495
- Jacqueline Milton Hicks$1,209,339
Others in their field
Top investigators on “Ensure”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Jeffrey P Krischer · University Of South Florida$385,823,280
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Gary D Acton · University Of California-Davis$320,373,312
- Michael David Hughes · Harvard University D/B/A Harvard School Of Public Health$315,257,203
Research focus
EnsureProviderRandomizedPhysiciansMelanomaParticipantPrimary Care PhysicianEarly DiagnosisLesionLong-Term SurvivorsMalignant NeoplasmsMedicalCostMorbidity - Disease RateCaringEarly TreatmentCellular PhoneRecurrenceHigh RiskFollow-UpDermatologistDermatologicDiagnosisReporting
Grant awards (21)
Technology-Enabled Activation of Skin Cancer Screening for Hematopoietic Cell Transplantation Survivors and their Primary Care Providers$748,780
R01 · FY2024 · CA
Technology-Enabled Activation of Skin Cancer Screening for Hematopoietic Cell Transplantation Survivors and their Primary Care Providers$798,150
R01 · FY2023 · CA
Technology-Enabled Activation of Skin Cancer Screening for Hematopoietic Cell Transplantation Survivors and their Primary Care Providers$806,562
R01 · FY2022 · CA
Technology-Enabled Activation of Skin Cancer Screening for Hematopoietic Cell Transplantation Survivors and their Primary Care Providers$838,645
R01 · FY2021 · CA
Technology-Enabled Activation of Skin Cancer Screening for Hematopoietic Cell Transplantation Survivors and their Primary Care Providers$909,366
R01 · FY2020 · CA
Reducing Skin Cancer Risk in Childhood Cancer Survivors$643,350
R01 · FY2017 · CA · contact PI
Reducing Skin Cancer Risk in Childhood Cancer Survivors$638,094
R01 · FY2016 · CA · contact PI
Reducing Skin Cancer Risk in Childhood Cancer Survivors$668,574
R01 · FY2015 · CA · contact PI
Reducing Skin Cancer Risk in Childhood Cancer Survivors$654,652
R01 · FY2014 · CA · contact PI
DISSEMINATION AND PUBLIC HEALTH PRACTICE$45,914
P50 · FY2014 · CA · contact PI
DISSEMINATION AND PUBLIC HEALTH PRACTICE$3,986
P50 · FY2014 · CA · contact PI
Reducing Skin Cancer Risk in Childhood Cancer Survivors$769,340
R01 · FY2013 · CA · contact PI
DISSEMINATION AND PUBLIC HEALTH PRACTICE$149,881
P50 · FY2013 · CA · contact PI
DISSEMINATION AND PUBLIC HEALTH PRACTICE$6,649
P50 · FY2012 · CA · contact PI
DISSEMINATION AND PUBLIC HEALTH PRACTICE$8,850
P50 · FY2011 · CA · contact PI
DISSEMINATION AND PUBLIC HEALTH PRACTICE$8,028
P50 · FY2010 · CA · contact PI
Tobacco Prevention/Cessation Education: Medical Students$184,882
R25 · FY2006 · CA · contact PI
Tobacco Prevention/Cessation Education: Medical Students$241,443
R25 · FY2005 · CA
Tobacco Prevention/Cessation Education: Medical Students$442,660
R25 · FY2004 · CA
Tobacco Prevention/Cessation Education: Medical Students$421,091
R25 · FY2003 · CA
Tobacco Prevention/Cessation Education: Medical Students$312,774
R25 · FY2002 · CA